RxDoctor Payments Data

Jessica Dickman

Family · Saint Louis, MONPI 1669940656

Payments from drug & device makers

$1,078in general payments, 2019–2025

Across 69 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$632
  • Bayer$96
  • Boehringer Ingelheim$49
  • Pfizer$45
  • Exact Sciences$35
  • Amgen$33
  • plus $188 from 9 others

What the payments were for

  • Food & beverage$1,078100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,078 in reported general payments places this provider in the 65th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$40,702
Medicare patients
169
Services billed
611

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$78,276
JardianceEmpagliflozin28$28,757
MounjaroTirzepatide22$22,689
EliquisApixaban11$13,423
FarxigaDapagliflozin Propanediol12$13,013
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,062
Albuterol Sulfate HfaAlbuterol Sulfate50$1,145
Nano 2nd Gen Pen NeedlePen Needle, Diabetic14$1,079
Gabapentin63$909
Rosuvastatin Calcium83$829
Atorvastatin Calcium66$749
Bupropion XlBupropion Hcl22$700
Mirtazapine24$672
Famotidine44$585
ValacyclovirValacyclovir Hcl11$550

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$30$78,27660 claims
Boehringer IngelheimJardiance$49$28,75728 claims
Lilly USA, LLCMounjaro$17$22,68922 claims
PfizerEliquis$45$13,42311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,812 family providers in Missouri.

Other family in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →